pharmaceutical investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical investing Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag)
Alvopetro Announces Q3 2026 Financial Results and an Operational Update Including 183-G2 Well Results